Google DeepMind releases AlphaGenome 2, which can predict the impact of DNA variants by cell type
Google DeepMind has released AlphaGenome 2, a model that can predict how different cell types interpret DNA, helping researchers connect genetic findings with the root causes of disease in specific cells. Built on AlphaGenome 1, it can predict the impact of DNA variants on specific cell types, and is used to reveal the cellular-level drivers of disease.
Why read this
AI score 65
Google DeepMind has launched a new version built on AlphaGenome 1, with a focus on predicting the impact of DNA variants by cell type.
Topics
Body
AlphaGenome 2 is helping uncover the cellular drivers of disease, giving scientists a powerful tool to predict how DNA variants impact specific cell types.
Every cell in our body shares the same DNA blueprint, but different cell types (like heart muscle cells vs. immune cells) read that blueprint differently. This new @GoogleDeepMind model predicts how these specialized cells interpret DNA, turning genetic code into biological insights.
Building on AlphaGenome 1 this makes it significantly easier for researchers to link genetic findings to the root causes of disease in the specific cells where they actually unfold.